Retour
46
14
Fourchette du Jour
8,60 €
8,83 €
Fourchette 52 Semaines
8,07 €
15,48 €
Volume
364 517
Moyenne 50J / 200J
9,02 €
/
11,35 €
Clôture Précédente
8,47 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 9,1 | 0,4 |
| P/B | 0,7 | 2,9 |
| ROE % | 9,6 | 3,7 |
| Net Margin % | 2,2 | 3,9 |
| Rev Growth 5Y % | 6,8 | 10,0 |
| D/E | 1,3 | 0,2 |
Objectif de Cours des Analystes
Hold
14,14 €
+63.7%
Low: 12,00 €
High: 19,00 €
P/E Prévisionnel
7,6
BPA Prévisionnel
1,14 €
Croissance BPA (est.)
+0,0%
CA Est.
6,6 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
1,34 €
1,07 € – 1,58 €
|
7,2 B | 6 |
| FY2027 |
1,26 €
1,02 € – 1,48 €
|
6,9 B | 6 |
| FY2026 |
1,14 €
1,03 € – 1,37 €
|
6,6 B | 7 |
Points Clés
Revenue grew 6,75% annually over 5 years — modest growth
Earnings declined -35,43% over the past year
Generating 258,61M in free cash flow
P/E of 9,11 — trading at a low valuation
Cash machine — converts 190,42% of earnings into free cash flow
Capital efficient — spends only 3,35% of revenue on capex
Croissance
Revenue Growth (5Y)
6,75%
Revenue (1Y)6,01%
Earnings (1Y)-35,43%
FCF Growth (3Y)75,16%
Qualité
Return on Equity
9,64%
ROIC6,18%
Net Margin2,15%
Op. Margin5,15%
Sécurité
Debt / Equity
1,34
Current Ratio1,97
Interest Coverage5,90
Valorisation
P/E Ratio
9,11
P/B Ratio0,73
EV/EBITDA8,58
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6,01% | Revenue Growth (3Y) | 8,13% |
| Earnings Growth (1Y) | -35,43% | Earnings Growth (3Y) | 64,33% |
| Revenue Growth (5Y) | 6,75% | Earnings Growth (5Y) | -3,13% |
| Profitability | |||
| Revenue (TTM) | 6,32B | Net Income (TTM) | 135,81M |
| ROE | 9,64% | ROA | 2,57% |
| Gross Margin | 97,54% | Operating Margin | 5,15% |
| Net Margin | 2,15% | Free Cash Flow (TTM) | 258,61M |
| ROIC | 6,18% | FCF Growth (3Y) | 75,16% |
| Safety | |||
| Debt / Equity | 1,34 | Current Ratio | 1,97 |
| Interest Coverage | 5,90 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 9,11 | P/B Ratio | 0,73 |
| P/S Ratio | 0,20 | PEG Ratio | -0,23 |
| EV/EBITDA | 8,58 | Dividend Yield | 0,00% |
| Market Cap | 1,24B | Enterprise Value | 2,79B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6,32B | 5,97B | 5,41B | 5,13B | 4,87B |
| Net Income | 135,81M | 210,34M | 50,29M | 188,91M | 154,26M |
| EPS (Diluted) | 0,96 | 1,58 | 0,35 | 1,32 | 1,08 |
| Gross Profit | 6,17B | 4,93B | 5,27B | 4,17B | 3,94B |
| Operating Income | 325,58M | 405,76M | 229,50M | 217,03M | 436,56M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2018 |
|---|---|---|---|---|---|
| Total Assets | 5,29B | 4,96B | 5,10B | 4,86B | 2,75B |
| Total Liabilities | 3,61B | 3,43B | 4,02B | 3,81B | 2,03B |
| Shareholders' Equity | 1,69B | 1,13B | 670,90M | 639,05M | 331,65M |
| Total Debt | 2,26B | 2,28B | 2,40B | 2,39B | 1,26B |
| Cash & Equivalents | 709,60M | 556,79M | 437,58M | 456,12M | 59,66M |
| Current Assets | 2,06B | 1,83B | 1,62B | 1,41B | 860,42M |
| Current Liabilities | 1,05B | 945,42M | 994,10M | 808,60M | 624,83M |
Scores de Stratégies
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#491 of 1024
#507 of 616
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026